{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:11:39Z","timestamp":1792015899118,"version":"4.4.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:00Z","timestamp":1784937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:00Z","timestamp":1784937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100013779","name":"Sabzevar University of Medical Sciences","doi-asserted-by":"crossref","award":["403395"],"award-info":[{"award-number":["403395"]}],"id":[{"id":"10.13039\/501100013779","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"DOI":"10.1007\/s12029-026-01539-2","type":"journal-article","created":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T10:26:58Z","timestamp":1784975218000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prioritizing Chemotherapy in Total Neoadjuvant Therapy Improves pCR Rate in Locally Advanced Rectal Cancer in Countries with Limited Radiotherapy Access: A Randomized Controlled Trial"],"prefix":"10.1007","volume":"57","author":[{"given":"Zahra","family":"Taheri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaheh","family":"Emadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Mohammad","family":"Esfandiary Rad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James S.","family":"Welsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasaman","family":"Mohebbifar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Jalili Bazel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Noferesti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maedeh","family":"Hamrah Siyani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danial","family":"Fazilat-Panah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freshte","family":"Foroughi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pejman","family":"Porouhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babak","family":"PeyroShabany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2467-837X","authenticated-orcid":false,"given":"Seyed Alireza","family":"Javadinia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roham","family":"Salek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,25]]},"reference":[{"issue":"2","key":"1539_CR1","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1159\/000543921","volume":"106","author":"T Matsuda","year":"2025","unstructured":"Matsuda T, Fujimoto A, Igarashi Y. Colorectal cancer: epidemiology, risk factors, and public health strategies. Digestion. 2025;106(2):91\u20139.","journal-title":"Digestion"},{"key":"1539_CR2","doi-asserted-by":"publisher","unstructured":"Liu F, Yu L, Zhao Y, Li G, He X. Organ function preservation in locally advanced low rectal cancer through total neoadjuvant therapy: a case report and literature review. Cancer Manage Res. 2025;17(0):121\u20139. https:\/\/doi.org\/10.2147\/CMAR.S499531.","DOI":"10.2147\/CMAR.S499531"},{"issue":"3","key":"1539_CR3","doi-asserted-by":"publisher","first-page":"912","DOI":"10.3390\/jcm14030912","volume":"14","author":"H-D Li\u0219cu","year":"2025","unstructured":"Li\u0219cu H-D, Verga N, Atasiei D-I, Ilie A-T, Vrabie M, Ro\u0219u L, et al. Therapeutic management of locally advanced rectal cancer: existing and prospective approaches. J Clin Med. 2025;14(3):912.","journal-title":"J Clin Med"},{"issue":"6","key":"1539_CR4","doi-asserted-by":"publisher","first-page":"zrac085","DOI":"10.1093\/bjsopen\/zrac085","volume":"6","author":"H\u00d8 Kristensen","year":"2022","unstructured":"Kristensen H\u00d8, Thy\u00f8 A, Emmertsen KJ, Smart NJ, Pinkney T, Warwick AM, et al. Surviving rectal cancer at the cost of a colostomy: global survey of long-term health-related quality of life in 10 countries. BJS open. 2022;6(6):zrac085.","journal-title":"BJS open"},{"issue":"5","key":"1539_CR5","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/sj.bjc.6603627","volume":"96","author":"M Morris","year":"2007","unstructured":"Morris M, Platell C, Fritschi L, Iacopetta B. Failure to complete adjuvant chemotherapy is associated with adverse survival in stage III colon cancer patients. Br J Cancer. 2007;96(5):701\u20137.","journal-title":"Br J Cancer"},{"issue":"1","key":"1539_CR6","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1186\/s12885-021-08183-y","volume":"21","author":"J \u017bok","year":"2021","unstructured":"\u017bok J, Bie\u0144kowski M, Radecka B, Korniluk J, Adamowicz K, Duchnowska R. Impact of relative dose intensity of oxaliplatin in adjuvant therapy among stage III colon cancer patients on early recurrence: a retrospective cohort study. BMC Cancer. 2021;21(1):529.","journal-title":"BMC Cancer"},{"key":"1539_CR7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.radonc.2020.03.011","volume":"147","author":"MJ van der Valk","year":"2020","unstructured":"van der Valk MJ, Marijnen CA, van Etten B, Dijkstra EA, Hilling DE, Kranenbarg EM-K, et al. Compliance and tolerability of short-course radiotherapy followed by preoperative chemotherapy and surgery for high-risk rectal cancer\u2013Results of the international randomized RAPIDO-trial. Radiother Oncol. 2020;147:75\u201383.","journal-title":"Radiother Oncol"},{"key":"1539_CR8","doi-asserted-by":"publisher","unstructured":"YAGHOBI JA, Behzadi B, Azadeh P, Alahyari S. The outcome of induction chemotherapy, followed by neoadjuvant chemoradiotherapy and surgery, in locally advanced rectal cancer. Iran J Pathol. 2021;16(3):266\u201373. https:\/\/doi.org\/10.30699\/IJP.2021.130482.2441.","DOI":"10.30699\/IJP.2021.130482.2441"},{"issue":"2","key":"1539_CR9","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S1470-2045(24)00678-8","volume":"26","author":"FY Moraes","year":"2025","unstructured":"Moraes FY, Gouveia AG, Bratti VF, Dee EC, Pavoni JF, Carson LM, et al. Global linear accelerator requirements and personalised country recommendations: a cross-sectional, population-based study. Lancet Oncol. 2025;26(2):239\u201348.","journal-title":"Lancet Oncol"},{"key":"1539_CR10","doi-asserted-by":"publisher","unstructured":"Aghili M, Farhan F, Babaei M, Ghalehtaki R, Yamrali M, Farazmand B et al. Outcomes of neoadjuvant radiochemotherapy of locally advanced rectal adenocarcinoma: results of 8 year experience in Iran cancer institute. Int J Cancer Manage. 2017;10(12):e12339. https:\/\/doi.org\/10.5812\/ijcm.12339.","DOI":"10.5812\/ijcm.12339"},{"issue":"3","key":"1539_CR11","doi-asserted-by":"publisher","first-page":"266","DOI":"10.30699\/ijp.2021.130482.2441","volume":"16","author":"AY Joybari","year":"2021","unstructured":"Joybari AY, Behzadi B, Azadeh P, Alahyari S. The outcome of induction chemotherapy, followed by neoadjuvant chemoradiotherapy and surgery, in locally advanced rectal cancer. Iran J Pathol. 2021;16(3):266.","journal-title":"Iran J Pathol"},{"key":"1539_CR12","doi-asserted-by":"publisher","first-page":"1468279","DOI":"10.3389\/fonc.2024.1468279","volume":"14","author":"F Foroughi","year":"2024","unstructured":"Foroughi F, Javadinia SA, Salek R. A randomized phase 3 trial of total neoadjuvant therapy (induction chemotherapy, neoadjuvant chemoradiation, neoadjuvant chemotherapy, and surgery) vs. standard long-term chemoradiation therapy (neoadjuvant chemoradiation, surgery, and adjuvant chemotherapy) in locally advanced rectal cancer. Front Oncol. 2024;14:1468279.","journal-title":"Front Oncol"},{"issue":"1","key":"1539_CR13","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/ags3.12389","volume":"5","author":"F Ali","year":"2021","unstructured":"Ali F, Keshinro A, Weiser MR. Advances in the treatment of locally advanced rectal cancer. Annals gastroenterological Surg. 2021;5(1):32\u20138.","journal-title":"Annals gastroenterological Surg"},{"issue":"6","key":"1539_CR14","doi-asserted-by":"publisher","first-page":"e180071","DOI":"10.1001\/jamaoncol.2018.0071","volume":"4","author":"A Cercek","year":"2018","unstructured":"Cercek A, Roxburgh CS, Strombom P, Smith JJ, Temple LK, Nash GM, et al. Adoption of total neoadjuvant therapy for locally advanced rectal cancer. JAMA Oncol. 2018;4(6):e180071\u2013e.","journal-title":"JAMA Oncol"},{"issue":"1","key":"1539_CR15","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S1470-2045(20)30555-6","volume":"22","author":"RR Bahadoer","year":"2021","unstructured":"Bahadoer RR, Dijkstra EA, van Etten B, Marijnen CA, Putter H, Kranenbarg EM-K, et al. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22(1):29\u201342.","journal-title":"Lancet Oncol"},{"issue":"5","key":"1539_CR16","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/S1470-2045(21)00079-6","volume":"22","author":"T Conroy","year":"2021","unstructured":"Conroy T, Bosset J-F, Etienne P-L, Rio E, Fran\u00e7ois \u00c9, Mesgouez-Nebout N, et al. Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22(5):702\u201315.","journal-title":"Lancet Oncol"},{"issue":"3","key":"1539_CR17","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1097\/SLA.0000000000003471","volume":"271","author":"F Petrelli","year":"2020","unstructured":"Petrelli F, Trevisan F, Cabiddu M, Sgroi G, Bruschieri L, Rausa E, et al. Total neoadjuvant therapy in rectal cancer: a systematic review and meta-analysis of treatment outcomes. Ann Surg. 2020;271(3):440\u20138.","journal-title":"Ann Surg"},{"issue":"23","key":"1539_CR18","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1200\/JCO.22.00032","volume":"40","author":"J Garcia-Aguilar","year":"2022","unstructured":"Garcia-Aguilar J, Patil S, Gollub MJ, Kim JK, Yuval JB, Thompson HM, et al. Organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy. J Clin Oncol. 2022;40(23):2546\u201356.","journal-title":"J Clin Oncol"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-026-01539-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-026-01539-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-026-01539-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T10:26:59Z","timestamp":1784975219000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-026-01539-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,25]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1539"],"URL":"https:\/\/doi.org\/10.1007\/s12029-026-01539-2","relation":{},"ISSN":["1941-6636"],"issn-type":[{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,25]]},"assertion":[{"value":"19 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Ethics Committees of Mashhad University of Medical Sciences (UMS) (IR.MUMS.MEDICAL.REC.1401.053) and Sabzevar UMS (IR.MEDSAB.REC.1404.034 and IR.MEDSAB.REC.1402.089). This trial was performed in accordance with the Declaration of Helsinki, and informed consent was obtained in writing from all patients.","order":1,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the preparation of this work, the authors used Sider (GPT-4.1 mini) to improve readability and language. After using this service, the authors reviewed and edited the content as needed and take full responsibility for the content of the publication.","order":3,"name":"Ethics","label":"Generative AI and AI-Assisted Technologies in the Writing Process","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study has been registered with the code IRCT20220723055527N1 and IRCT20250920067300N1 in the Iranian Clinical Trials Registry.","order":4,"name":"Ethics","label":"Trial Registration","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"163"}}